Schedule 13G ownership disclosure

Amphastar Pharmaceuticals Inc

Security class unavailable · CUSIP: 03209R103

Event date: 2024-02-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.5200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001623632-24-000361
Form type
SC 13G/A
Filer
Amphastar Pharmaceuticals, Inc.
CIK
CIK 1297184
Filed
Mar 06, 2024
Reporting period
Feb 29, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub